Merrimack Pharmaceuticals,Inc. Company Profile

09:38 EDT 20th March 2018 | BioPortfolio

Merrimack Pharmaceuticals, Inc. is a privately held biotechnology company based in Cambridge, Massachusetts. We are dedicated to the discovery and development of innovative therapies for the treatment of autoimmune disease and cancer. Our goal is to provide patients and physicians with not only the best possible treatments, but to support our pharmaceuticals with the tools to enable the prescription of the right drug for the right patient.Merrimack is advancing a robust pipeline of clinical and early-stage biologics that represent the next generation of patient-directed, targeted therapies. Our discovery and development efforts are founded on our proprietary Network Biology research engine and the talents and expertise of our employees. Our lead product, MM-093, is currently in Phase 2 clinical trials for the treatment of patients with rheumatoid arthritis and psoriasis.


101 Binney Street
United States of America


Phone: 617-441-1000
Fax: 617-491-1386

News Articles [514 Associated News Articles listed on BioPortfolio]

Merrimack Commences Tender Offer For Any And All Of Its Outstanding 4.50% Convertible Senior Notes Due 2020

CAMBRIDGE, Mass., Oct. 13, 2017 /PRNewswire/ -- Merrimack Pharmaceuticals (NASDAQ: MACK) (the "Company" or "Merrimack") today announced that it has commenced a tender offer (the "Tender Offer") to pur...

FDA orphan status given to Merrimack's heregulin-positive lung cancer drug

Merrimack Pharmaceuticals' MM-121, or seribantumab, which is being developed to treat patients with heregulin-positive non-sm -More- 

Investor Network: Merrimack Pharmaceuticals, Inc. to Host Earnings Call

NEW YORK, NY / ACCESSWIRE / March 12, 2018 / Merrimack Pharmaceuticals, Inc. (NASDAQ: MACK) will be discussing their earnings results in their Q4 Earnings Call to be held on March 12, 2018 at 8:30 ...

Merrimack Pharmaceuticals Expands Phase II Lung Cancer Study

Merrimack Pharmaceuticals announced it is expanding enrollment in a Phase II lung cancer study.

Ex-Merrimack, Seragon Execs’ New Startup Gets $60M, Buys Sanofi Drug

Partner Therapeutics, a Boston startup launched last week by a pair of former Merrimack Pharmaceuticals and Seragon Pharmaceuticals executives, has raised $60 million and acquired an immune system-bo...

Former Merrimack Exec Mulroy Surfaces as Partner Therapeutics CEO

Robert Mulroy is now CEO of Partner Therapeutics, a Boston cancer drug developer. Mulroy was co-founder and CEO of Cambridge-based Merrimack Pharmaceuticals (NASDAQ: MACK). Partner also named Debasish...

Merrimack Reports Third Quarter 2017 Financial Results

"The third quarter marked continued execution on our 2017 goals as we delivered on the promise of a refocused Merrimack with a seasoned team built Read more...

Merrimack Pharmaceuticals' (MACK) CEO Richard Peters on Q4 2017 Results - Earnings Call Transcript

Drugs and Medications [270 Associated Drugs and Medications listed on BioPortfolio]

Pur-wash [Niagara Pharmaceuticals Inc.]


Bacitracin [Qualitest Pharmaceuticals]

Bacitracin Ointment, USP

Pur-wash [Niagara Pharmaceuticals Inc.]

Pur-Wash Purified Water, 98.3% Ophthalmic Solution Eyewash

Antacid [Major Pharmaceuticals]

Major Pharmaceuticals Antacid Tablets Drug Facts

Eyewash station additive concentrate [Niagara Pharmaceuticals Inc.]


PubMed Articles [118 Associated PubMed Articles listed on BioPortfolio]

Suspended solids moderate the degradation and sorption of waste water-derived pharmaceuticals in estuarine waters.

This study focuses on the fate of pharmaceuticals discharged into an estuarine environment, particularly into the Turbidity Maximum Zone (TMZ). Batch experiments were set up to investigate the factors...

Chiral pharmaceuticals: A review on their environmental occurrence and fate processes.

More than 50% of pharmaceuticals in current use are chiral compounds. Enantiomers of the same pharmaceutical have identical physicochemical properties, but may exhibit differences in pharmacokinetics,...

Genetics of familial hypercholesterolemia: a tool for development of novel lipid lowering pharmaceuticals?

Familial hypercholesterolemia is characterized by high LDL cholesterol and an elevated risk to develop coronary heart disease. Mutations in LDL receptor-mediated cholesterol uptake are the main cause ...

A General Strategy for Site-Selective Incorporation of Deuterium and Tritium into Pyridines, Diazines and Pharmaceuticals.

Methods to incorporate deuterium and tritium atoms into organic molecules are valuable for medicinal chemistry. The prevalence of pyridines and diazines in pharmaceuticals means that new ways to label...

Effects of exposure to pharmaceuticals (diclofenac and carbamazepine) spiked sediments in the midge, Chironomus riparius (Diptera, Chironomidae).

Human and veterinary pharmaceuticals and degradation products are continuously introduced into the environment. To date, there is a lack of information about the effects of pharmaceuticals in spiked t...

Clinical Trials [211 Associated Clinical Trials listed on BioPortfolio]

Safety and Efficacy Study of MM-093 in Patients With Chronic Plaque Psoriasis

Merrimack is conducting a research study to see if an experimental drug, called MM-093, is safe and effective in the treatment of psoriasis. MM-093 is a genetically engineered version of a...

Study Comparing Citalopram Hydrobromide Tablets 40 mg (Torrent Pharmaceuticals Ltd) and RLD Tablets 40 mg (Manufactured By Forest Pharmaceuticals Inc, Missouri) in 24+2 Normal Healthy Male Subjects in Fed Condition

- Objective: - The objective of this study is to compare the rate and extent of absorption of the Test Product, Citalopram Hydrobromide 40 mg (Torrent Pharmaceutical Li...

Bioequivalence Study of Torrent Pharmaceuticals Ltd.'s Rosuvastatin Calcium Tablets Under Fed Conditions

Subjects to compare the single dose bioavailability of Torrent's Rosuvastatin Calcium Tablets 40 mg and Crestor® 40 mg Tablets of AstraZeneca Pharmaceuticals LP, USA. Dosing periods of st...

Cilostazol 50 mg Tablets Under Fasting Conditions

This study will compare the relative bioavailability (rate and extent of absorption) of 50 mg Cilostazol Tablets manufactured by TEVA Pharmaceuticals Industries Ltd. and distributed by TEV...

Study Comparing Citalopram Hydrobromide Tablets 40 mg (Torrent Pharmaceuticals Ltd) and RLD Tablets 40 mg (Manufactured By Forest Pharmaceuticals Inc, Missouri) in 24+2 Normal Healthy Male Subjects Under Fasting Condition

- Objective: - To compare the rate and extent of absorption of Citalopram Hydrobromide Tablets 40 mg: Test Product: Citalopram Hydrobromide Tablets 40 mg manufactured b...

Companies [1309 Associated Companies listed on BioPortfolio]

Merrimack Pharmaceuticals,Inc.

Merrimack Pharmaceuticals, Inc. is a privately held biotechnology company based in Cambridge, Massachusetts. We are dedicated to the discovery and development of innovative therapies for the treatmen...

Merrimack Pharmaceuticals, Inc.

Merrimack Pharmaceuticals, Inc. is a biopharmaceutical company dedicated to the discovery and development of novel medicines for the treatment of cancer and inflammation. The Company is advancing a ro...

HD Merrimack

PharmaEngine Inc.

PharmaEngine, Inc. is a biopharmaceutical company established in Taipei, Taiwan in 2003. PharmaEngine focuses on the development of new treatments for cancer and Asian prevalent d...

Maelor Pharmaceuticals Ltd.

Maelor is a publicly listed (AIM:MLR) specialist critical care pharmaceuticals and devices company. The Company has developed an expertise in bringing both pharmaceuticals and devices to the market as...

More Information about "Merrimack Pharmaceuticals,Inc." on BioPortfolio

We have published hundreds of Merrimack Pharmaceuticals,Inc. news stories on BioPortfolio along with dozens of Merrimack Pharmaceuticals,Inc. Clinical Trials and PubMed Articles about Merrimack Pharmaceuticals,Inc. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Merrimack Pharmaceuticals,Inc. Companies in our database. You can also find out about relevant Merrimack Pharmaceuticals,Inc. Drugs and Medications on this site too.

Quick Search


Relevant Topics

Antibodies Antisense Assays Biochips Bioinformatics Biological Therapy Biomarkers Biomaterials Bioscience Cell Culture Cloning Cytokine Diagnostics Dna Extraction Dna Sequencing Dna Transform...

Drug Discovery
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...

Autoimmune Disorders
Autoimmune disorders are conditions that occurs when the immune system mistakenly attacks and destroys healthy body tissue. There are more than 80 different types of autoimmune disorders. Normally the immune system's white blood cells help protect ...

Corporate Database Quicklinks

Searches Linking to this Company Record